Tempus Unveils New Whole-Genome Sequencing Assay
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Read MorePosted by Andy Lundin | Jan 15, 2025 | Hematology & Serology, Molecular Diagnostics |
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Read MorePosted by Andy Lundin | Jan 14, 2025 | Compliance |
Xifin’s CEO sees a window of opportunity for lawmakers to modify the Final Rule on LDTs that will be a win-win for the industry and patients.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Lung Cancer |
The ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read MorePosted by Andy Lundin | Jan 9, 2025 | Molecular Diagnostics |
A study found that an FDA-approved genetic test for opioid use disorder risk may produce high rates of false positives and false negatives.
Read MorePosted by Andy Lundin | Jan 9, 2025 | Cancer, Molecular Diagnostics |
Summary: A Mayo Clinic-led international study utilized CRISPR-Cas9 technology to classify 91% of...
Read More